Pharma's pervasive 'evergreening' is driving prices up, study says
admin 3rd November 2017 Uncategorised 0Anyone who follows the pharma industry can tell you the intellectual property landscape for drugs is ever-changing, with add-on patents and invalidations periodically extending and upending protections for top meds. Now, new research takes a wide look at the strategy of “evergreening,” or adding new patents to extend a drug’s exclusivity.
More: Pharma's pervasive 'evergreening' is driving prices up, study says
Source: fierce